Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -133.54%-38.76K | 85.48%-146.53K | 95.99%-38.15K | -54.85%48.47K | -1,826.03%-140.26K | 90.37%-16.6K | 53.59%-1.01M | -165.06%-952.34K | 116.51%107.36K | 101.16%8.13K |
| Net income from continuing operations | 44.86%-230.9K | -77.17%-4.34M | -72.35%-3.23M | 39.15%-196.1K | -344.04%-502K | -190.48%-418.77K | 34.94%-2.45M | 8.39%-1.87M | 44.14%-322.26K | 83.76%-113.05K |
| Operating gains losses | ---- | -99.71%549 | --226.03K | ---14.13K | ---84.95K | ---126.41K | --192.5K | ---- | ---- | ---- |
| Depreciation and amortization | -89.17%2.54K | -7.77%91.78K | -14.04%21.39K | -5.68%23.47K | -5.68%23.47K | -5.68%23.47K | 32.02%99.51K | -37.68%24.88K | 110.50%24.88K | 110.52%24.88K |
| Asset impairment expenditure | ---- | -64.50%421.62K | ---- | ---- | ---- | ---- | 2,190.77%1.19M | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---6.66K | 1,305.93%2.15M | 1,287.26%2.12M | --0 | --33.28K | --0 | -2,595.42%-178.2K | ---178.2K | --0 | ---- |
| Remuneration paid in stock | --0 | -42.83%170.94K | --0 | --0 | --0 | --170.94K | --299.01K | --299.01K | --0 | --0 |
| Other non cashItems | ---- | 3.64%51.11K | -95.95%2.61K | 78.56%-2.13K | 132.04%865 | 2,192.72%49.77K | -82.92%49.31K | -78.11%64.33K | -475.00%-9.94K | -27.78%-2.7K |
| Change In working capital | -31.00%196.25K | 731.36%1.31M | 159.73%400.58K | -42.76%237.36K | 293.01%389.08K | 660.33%284.41K | -117.76%-207.72K | -151.94%-670.64K | 596.05%414.68K | 735.75%99K |
| -Change in receivables | 86.92%-742 | 223.90%104.15K | 105.72%3.45K | 808.98%114.93K | -131.46%-8.55K | -45.25%-5.67K | -139.25%-84.06K | -125.79%-60.25K | 67.38%-16.21K | 91.68%-3.69K |
| -Change in inventory | --718 | 6,499.67%40.52K | 15,273.95%33.05K | --216 | 1,920.06%7.25K | --0 | --614 | --215 | --0 | --359 |
| -Change in prepaid assets | 50.36%-12.9K | 301.81%86.16K | 283.75%86.26K | 610.55%19.54K | -41.19%6.34K | -180.06%-25.98K | -275.94%-42.69K | -188.28%-46.94K | 110.19%2.75K | -8.87%10.78K |
| -Change in payables and accrued expense | -33.82%209.17K | 1,424.66%1.08M | 149.29%277.82K | -76.02%102.68K | 319.45%384.04K | 940.18%316.06K | -108.76%-81.58K | -156.12%-563.66K | 6,297.76%428.14K | 438.61%91.56K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -133.54%-38.76K | 85.48%-146.53K | 95.99%-38.15K | -54.85%48.47K | -1,826.03%-140.26K | 90.37%-16.6K | 53.59%-1.01M | -165.06%-952.34K | 116.51%107.36K | 101.16%8.13K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 79.99%-138.26K | -108.57%-38.26K | ||||||
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | 62.98%-138.26K | -12.68%-38.26K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | ---- | ---- | ---- | 79.99%-138.26K | -108.57%-38.26K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -64.19%59.63K | -84.80%146.9K | -100.28%-2.8K | 0.00%-8.4K | 0.00%-8.4K | 2,082.14%166.5K | 2,976.19%966.4K | 11,904.76%991.6K | 0.00%-8.4K | 0.00%-8.4K |
| Net issuance payments of debt | --0 | 16.67%-28K | 66.67%-2.8K | 0.00%-8.4K | 0.00%-8.4K | 0.00%-8.4K | 0.00%-33.6K | 0.00%-8.4K | 0.00%-8.4K | 0.00%-8.4K |
| Net common stock issuance | --0 | -82.51%174.9K | --0 | --0 | --0 | --174.9K | --1M | --1M | --0 | --0 |
| Proceeds from stock option exercised by employees | --59.63K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -64.19%59.63K | -84.80%146.9K | -100.28%-2.8K | 0.00%-8.4K | 0.00%-8.4K | 2,082.14%166.5K | 2,976.19%966.4K | 11,904.76%991.6K | 0.00%-8.4K | 0.00%-8.4K |
| Net cash flow | ||||||||||
| Beginning cash position | 33.85%1.47K | -99.40%1.1K | 42,743.43%42.42K | 106.07%2.34K | 10,609.08%151K | -99.40%1.1K | -94.09%182.24K | -99.90%99 | -99.89%1.14K | -99.95%1.41K |
| Current changes in cash | -86.08%20.86K | 100.20%371 | -4,207.12%-40.95K | 3,964.42%40.07K | -54,154.38%-148.66K | 182.90%149.9K | 93.75%-181.14K | -98.73%997 | 99.89%-1.04K | 99.98%-274 |
| End cash Position | -85.21%22.33K | 33.85%1.47K | 33.85%1.47K | 42,743.43%42.42K | 106.07%2.34K | 10,609.08%151K | -99.40%1.1K | -99.40%1.1K | -99.90%99 | -99.89%1.14K |
| Free cash from | -133.54%-38.76K | 85.48%-146.53K | 95.99%-38.15K | -54.85%48.47K | -1,826.03%-140.26K | 90.37%-16.6K | 58.68%-1.01M | -886.31%-952.34K | 112.55%107.36K | 100.65%8.13K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.